Astellas' VEOZA™ (fezolinetant) Approved by European Commission for[...]
Incyte and Syndax Present Additional Data from Positive AGAVE-201 Trial[...]
09/26/2023 | Press release | Distributed by Public on 09/26/2023 07:25
Please select the service you want to use:
Smartlinks | Private Shares Fund | Company News | Financial Services | Investment Funds | Mutual Funds | Investment Services | Securities Issuers | Mutual Funds | Nasdaq Capital Market
Back
Copyright ©2006-2023 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact